Advertisement

Rationnel du dépistage

  • É. Mitry
Part of the Dépistage et cancer book series (DC)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Remontet L, Esteve J, Bouvier AM et al. (2003) Cancer incidence and mortality in France over the period 1978–2000. Rev Épidemiol Santé Publique 51: 3–30PubMedGoogle Scholar
  2. 2.
    Bedenne L, Faivre J, Boutron MC et al. (1992) Adenoma-carcinoma sequence or “de novo” carcinogenesis? A study of adenomatous remnants in a populationbased series of large bowel cancers. Cancer 69: 883–8PubMedCrossRefGoogle Scholar
  3. 3.
    Winawer SJ, Zauber AG, O’Brien MJ et al. (1993) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328: 901–6PubMedCrossRefGoogle Scholar
  4. 4.
    Jorgensen O, Kronborg O, Fenger C (1995) A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas. The Funen Adenoma follow-up study. Scand J Gastroenterol 30: 686–92PubMedGoogle Scholar
  5. 5.
    Bretagne JF, Faivre J (2000) La Société Nationale Française de Gastroentérologie recommande la mise en place d’un dépistage généralisé et organisé du cancer colorectal en France. Gastroenterol Clin Biol 24: 492–3PubMedGoogle Scholar
  6. 6.
    Conférence de consensus (1998) Prévention, dépistage et prise en charge des cancers du côlon. Gastroenterol Clin Biol 22: 205–26Google Scholar
  7. 7.
    Greegor DH (1967) Diagnosis of large-bowel cancer in the asymptomatic patient. Jama 201: 943–5PubMedCrossRefGoogle Scholar
  8. 8.
    Young GP, St John DJ, Winawer SJ et al. (2002) Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97: 2499–507PubMedGoogle Scholar
  9. 9.
    (2000) Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention. Eur J Cancer 36: 1473–8CrossRefGoogle Scholar
  10. 10.
    Yamamoto M, Nakama H (2000) Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. Hepatogastroenterology 47: 396–9PubMedGoogle Scholar
  11. 11.
    Ransohoff DF, Lang CA (1997) Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med 126: 811–22PubMedGoogle Scholar
  12. 12.
    Bertario L, Spinelli P, Gennari L et al. (1988) Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci 33: 609–13PubMedCrossRefGoogle Scholar
  13. 13.
    Macrae FA, St John DJ (1982) Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 82: 891–8PubMedGoogle Scholar
  14. 14.
    Launoy G, Smith TC, Duffy SW, Bouvier V (1997) Colorectal cancer mass-screening: estimation of fæcal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 73: 220–4PubMedCrossRefGoogle Scholar
  15. 15.
    Jouve JL, Remonte L, Dancourt V et al. (2001) Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening. Br J Cancer 84:1477–81PubMedCrossRefGoogle Scholar
  16. 16.
    Gyrd-Hansen D, Sogaard J, Kronborg O (1997) Analysis of screening data: colorectal cancer. Int J Epidemiol 26: 1172–81PubMedCrossRefGoogle Scholar
  17. 17.
    Lieberman DA, Weiss DG, Bond JH et al. (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343: 162–8PubMedCrossRefGoogle Scholar
  18. 18.
    Mandel JS, Bond JH, Church TR et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365–71PubMedCrossRefGoogle Scholar
  19. 19.
    Pignone M, Campbell MK, Carr C et al. (2001) Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 4: 150–6PubMedGoogle Scholar
  20. 20.
    Jaffe RM, Kasten B, Young DS et al. (1975) False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 83: 824–6PubMedGoogle Scholar
  21. 21.
    Selby JV, Friedman GD, Quesenberry CP et al. (1993) Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 118: 1–6PubMedGoogle Scholar
  22. 22.
    Wahrendorf J, Robra BP, Wiebelt H et al. (1993) Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 2: 221–7PubMedGoogle Scholar
  23. 23.
    Lazovich D, Weiss NS, Stevens NG et al. (1995) A case-control study to evaluate efficacy of screening for fæcal occult blood. J Med Screening 2: 84–89Google Scholar
  24. 24.
    Zappa M, Castiglione G, Grazzini G et al. (1997) Effect of fæcal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer 73: 208–10PubMedCrossRefGoogle Scholar
  25. 25.
    Faivre J, Tazi MA, El Mrini T et al. (1999) Fæcal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 79:680–3PubMedCrossRefGoogle Scholar
  26. 26.
    Saito H, Soma Y, Koeda J et al. (1995) Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 61: 465–9PubMedGoogle Scholar
  27. 27.
    Mandel JS, Church TR, Ederer F et al. (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91: 434–7PubMedCrossRefGoogle Scholar
  28. 28.
    Kewenter J, Bjork S, Haglind E et al. (1988) Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 62: 645–51PubMedCrossRefGoogle Scholar
  29. 29.
    Hardcastle JD, Chamberlain JO, Robinson MEH et al. (1996) Randomised controlled trial of fæcal-occult-blood screening for colorectal cancer. Lancet 348: 1472–77PubMedCrossRefGoogle Scholar
  30. 30.
    Kronborg O, Fenger C, Olsen J et al. (1996) Randomised study of screening for colorectal cancer with fæcal-occult-blood test. Lancet 348: 1467–71PubMedCrossRefGoogle Scholar
  31. 31.
    Faivre J, Dancourt V, Lejeune C et al. (2004) Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126: 1674–80PubMedCrossRefGoogle Scholar
  32. 32.
    Scholefield JH, Moss S, Sufi F et al. (2002) Effect of fæcal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 50: 840–844PubMedCrossRefGoogle Scholar
  33. 33.
    Jorgensen OD, Kronborg O, Fenger C (2002) A randomised study of screening for colorectal cancer using fæcal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50: 29–32PubMedCrossRefGoogle Scholar
  34. 34.
    Kronborg O, Jorgensen OD, Fenger C et al. (2004) Randomized study of biennial screening with a fæcal occult blood test: results after nine screening rounds. Scand J Gastroenterol 39: 846–51PubMedCrossRefGoogle Scholar
  35. 35.
    Towler BP, Irwig L, Glasziou P et al. (2003) Screening for colorectal cancer using the fæcal occult blood test, Hemoccult (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update softwareGoogle Scholar
  36. 36.
    Towler B, Irwig L, Glasziou P et al. (1998) A systematic review of the effects of screening for colorectal cancer using the fæcal occult blood test, hemoccult. Br Med J 317: 559–65Google Scholar
  37. 37.
    Mandel JS, Church TR, Bond JH et al. (2000) The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer. N Engl J Med 343: 1603–7PubMedCrossRefGoogle Scholar
  38. 38.
    Faivre J, Dancourt V (2002) Le dépistage du cancer colorectal. Certitudes et questions. Gastroenterol Clin Biol 26: B86–93PubMedGoogle Scholar

Copyright information

© Springer-Verlag France, Paris 2006

Authors and Affiliations

  • É. Mitry
    • 1
  1. 1.Service d’hépato-gastro-entérologie et oncologie digestiveCHU Ambroise-ParéBoulogneFrance

Personalised recommendations